239 filings
Page 2 of 12
DEFA14A
218 ney7hhzljpkudz96
8 Sep 21
Additional proxy soliciting materials
6:16am
8-K
nsv x84hh
8 Sep 21
Sanofi to acquire Kadmon to further strengthen growth of transplant business
6:15am
8-K
wii26cxhkfte
5 Aug 21
Kadmon Provides Business Update and Reports Second Quarter 2021 Financial Results
4:07pm
8-K
0q2g47yybjagsrj3oq4y
19 Jul 21
Other Events
4:05pm
8-K
om1rn70 7smmjuxi
12 May 21
Submission of Matters to a Vote of Security Holders
4:27pm
8-K
t7ks4c me29
6 May 21
Kadmon Provides Business Update and Reports First Quarter 2021 Financial Results
5:06pm
DEFA14A
ccpfu4at
3 May 21
Additional proxy soliciting materials
8:29am
DEFA14A
i3ojyevf lx1iw
1 Apr 21
Additional proxy soliciting materials
4:35pm
8-K
46tn sx3d
1 Apr 21
Other Events
4:01pm
8-K
te0k7ix5o7
10 Mar 21
Kadmon Announces U.S. FDA has Extended the Review Period for Belumosudil in Chronic Graft-Versus-Host Disease
4:16pm
S-8
98iyyrdzwlndy77zscan
5 Mar 21
Registration of securities for employees
4:06pm
8-K
edvahzvll51ux 8z
4 Mar 21
Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
4:02pm
8-K
lhwoq h7g
16 Feb 21
Entry into a Material Definitive Agreement
4:11pm
8-K
zlz93p
10 Feb 21
Kadmon Announces Proposed $150 Million Convertible Senior Notes Offering with Capped Call Transactions
4:00pm
8-K
24uu0xa
12 Jan 21
Departure of Directors or Certain Officers
4:16pm
8-K
h1ot 5dez
7 Dec 20
Kadmon Announces 12-Month Data from Pivotal Trial of Belumosudil for cGVHD at the 62nd ASH Annual Meeting
8:02am